Cruz JC, Allison KC, Page LS, Jenkins AJ, Wang X, Earp HS, Frye SV, Graham DK, Verneris MR, Lee-Sherick AB Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment. , Front Immunol, 14:1146721: 2023
Campbell RA, Manne BK, Banerjee M, Middleton E, Ajanel A, Schwertz H, Denorme F, Stubben C, Montenont E, Saperstein S, Page LS, Tolley ND, Lim DL, Brown SM, Grissom CK, Sborov DW, Krishnan A, Rondina M IFITM3 regulates fibrinogen endocytosis and platelet reactivity in nonviral sepsis. , J Clin Invest, 132 (23): e153014: 2022
Page LS, Pardanani S “A Look into the Accessibility of Human Papillomavirus Vaccination in a Stamford, Connecticut Community Clinic Population.” [Abstract]. Stamford Hospital, Affiliate of Columbia University Vagelos College of Physicians & Surgeons. Resident Research Day , : 2021
Griffiths TM, Page LS, Weyrich AS, Rondina MT, Campbell RA Platelet electrical resistance for measuring platelet activation and adhesion in human health and disease. , Thromb Res, 198: 204-209: 2021
Lee-Sherick AB, Jacobsen KM, Henry CJ, Huey MG, Parker RE, Page LS, Hill AA, Wang X, Frye SV, Earp HS, Jordan CT, DeRyckere D, Graham DK MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity. , JCI Insight, 3(21): e97941: 2018
Page LS, Campbell RA, Manne B, Weyrich A, Rondina MT “The Role of Increased Circulating Interferons and Platelet Interferon-Induced Transmembrane Proteins in Hyperactive Thrombo-Inflammation.” , University of Utah School of Medicine MSRP Conference: 2017
DeRyckere D, Lee Sherick AB, Huey MG, Hill AA, Tyner JW, Jacobsen KM, Page LS, Kirkpatrick GD, Eryildiz F, Montgomery SA, Zhang W, Wang X, Frye SV, Earp HS, Graham DK UNC2025, a MerTK small molecule inhibitor, is therapeutically effective alone and in combination with methotrexate in leukemia models. , Clinical Cancer Research, 23(14): 3971-3972: 2017
Page LS, Wang X, Earp HS, Frye SV, Jordan CT, Lee-Sherick AB “MerTK Receptor Tyrosine Kinase Inhibition As a Potential Strategy to Augment Immune-Mediated Clearance of Acute Myeloid Leukemia.” Poster Presentation , American Society of Hematology Annual Meeting, San Diego, CA: 2016
Lee-Sherick AB, Zhang W, Menachof K, Hill A, Rinella S, Kirkpatrick G, Page LS, Stashko M, Jordan C, Wei Q, Liu J, Zhang D, DeRyckere D, Wang X, Frye S, Earp H, Graham D Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia. , Oncotarget, 6(9): 6722-6736: 2015
Deryckere D, Lee-Sherick AB, Wang X, Hill AA, Zhang W, Page L, Frye SV, Shelton Earp HS “UNC2025, a small molecule MerTK and Flt3 tyrosine kinase inhibitor, has therapeutic activity and promotes sensitivity to chemotherapy in xenograft models of acute leukemia.” Poster Presentation, American Society of Hematology Annual Meeting, San Francisco, CA , Blood, 124:998: 2014
